'/%3E%3C/svg%3E%0A){kind=small}
February 28 marks Rare Disease Day, a time to raise awareness and generate change for the 300 million people worldwide living with a rare disease, along with their families and caregivers. This year’s theme, “more than you can imagine,” inspired us at Prothena to dream beyond the ordinary. We asked a few Prothenians, “What […]
February 11 marks International Day of Women and Girls in Science. Last year, Donna-Lee Destouche, Head of Clinical Trial Management at Prothena, shared advice on inspiring the next generation of female leaders in STEM. Today, we’re honored to hear from Chi Johnson, Associate Director of Facilities and Environment Health & Safety (EH&S) at Prothena. Chi’s […]
The prevalence and impact of Alzheimer’s disease varies by sex, race and ethnicity. In fact, according to the Alzheimer’s Association, nearly two-thirds of people living with Alzheimer’s disease are women. Black Americans are nearly twice as likely as White Americans to develop Alzheimer’s disease or another dementia, and Hispanic Americans are 1.5 times as likely. […]
This summer we shared the powerful story of LuPita, currently living with dementia. Today we are honored to introduce Jessica, LuPita’s daughter and care partner, in honor of November marking National Family Caregivers Month. Hear firsthand from Jessica on how she decided to take on the vital role, the importance of taking care of oneself […]
This month, we’re excited to hear from the newest member of our leadership team at Prothena! In September, Chad Swanson was appointed as Prothena’s new Chief Development Officer. A neuropharmacologist with over 20 years industry experience, Chad joined Prothena as Senior Vice President and Head of Clinical Development in January 2023. In his new role, […]
Tomorrow marks World Amyloidosis Day, and we at Prothena are proud to join the Amyloidosis Alliance to help raise awareness of amyloidosis, a complex disease often misunderstood and misdiagnosed by medical professionals and unheard of by the general public. In the below video, Steve, living with AL amyloidosis, talks about the difficult and long journey […]
From running marathons to developing potential breakthrough treatments, for Christie it’s all about perseverance At Prothena, our mission is to bring life-changing therapies to patients battling neurodegenerative and rare peripheral amyloid diseases. Our clinical development efforts play a vital role in moving these therapies from early research to potential treatments that could improve the lives […]
Saturday, on World Alzheimer’s Day, we at Prothena joined Alzheimer’s Disease International to raise awareness of Alzheimer’s disease and challenge the stigma of this disease and other dementias. We recently shared the story of LuPita, currently living with dementia. Today, we are honored to help Phil tell his story. In another powerful tale, Phil underscores […]
Alzheimer’s disease is a devastating form of dementia that causes memory, thinking and behavior problems. It is believed two different proteins – Aβ (amyloid beta) and tau – are the primary contributors to its pathology. Misfolded Aβ builds up to form plaques between nerve cells in the brain. Tangles of twisted tau fibrils spread from […]
Earlier this year, we heard advice for people living with AL amyloidosis from an AL amyloidosis patient herself, Linda. Today, we continue to elevate firsthand perspectives of people directly impacted by this rare disease. Hear from Donna, a wife and mother, and caregiver to her husband Mike who is living with AL amyloidosis. She describes […]
Prothena is committed to developing novel and transformative medicines to create a better future for patients with neurodegenerative and rare peripheral amyloid diseases, which affect millions of people and their families worldwide. Before any treatment is made available to patients in the U.S., it must go through a rigorous set of clinical and nonclinical testing […]
Today marks The Longest Day. It’s the summer solstice and the day with the most sunlight all year long. Also today, we stand with the Alzheimer’s community to fight the darkness of Alzheimer’s disease and all other dementias. There has been remarkable progress in the treatment of Alzheimer’s disease in the past few years, […]
AL amyloidosis, a rare, progressive and often fatal disease, occurs when a type of immune cell, called plasma cells, produce high levels of an abnormal protein called light chain that misfolds and clumps together to form aggregated amyloid which the body cannot break down. Clumped together, the amyloid can travel through blood vessels, damaging cells […]
Earlier this year we heard from Donna-Lee Destouche who shared advice on encouraging the next generation of female leaders in STEM. In her interview, she notes, “if we have some support to be ambitious in our career, and perhaps not lose a step because you’ve decided you wanted to start a family, we may have […]
Proteins are essential for life. Every cell in our body makes protein every day. And for those proteins to work correctly, they need to fold in a certain three-dimensional shape and space. Systems in our cells recognize misshapen proteins and try to fix them. If they can’t help fold them into the correct shape, the […]
March is Amyloidosis Awareness Month, and at Prothena we believe it’s important to shine light on firsthand perspectives from people directly impacted by the disease. In this video, Linda offers advice to those affected by AL amyloidosis. Whether advice for others impacted by the disease, the journey to diagnosis, or working together with a care […]
AL amyloidosis is a rare, progressive and life-threatening disease that leads to the production and aggregation of misfolded toxic light chain proteins. These aggregates cause problems in the body’s circulation, depositing in the heart and kidney, leading to damage and organ failure. Patients often present with a wide range of general symptoms that are common […]